Form 4: OS Therapies Director John Ciccio Reports Share Acquisitions Following IPO Conversion

Director John Ciccio reports acquisition of OS Therapies shares through conversion of convertible promissory notes held by Mill River Partners LLC upon the company's initial public offering.

Summary

• On August 2, 2024, John Ciccio, a director of OS Therapies Inc., reported the acquisition of common stock due to the automatic conversion of convertible promissory notes held by Mill River Partners LLC (MRP) upon the consummation of the Issuer's initial public offering.
• The conversions involved three notes with principal amounts of $25,000, $75,000, and $50,000, converting at prices of $0.39 and $2.00 per share.
• Ciccio's beneficial ownership following the reported transactions includes 20,000 shares held directly and 435,835 shares held indirectly through Mill River Partners LLC, where he serves on the board of managers and shares voting and investment power.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock ownership changes following an IPO. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure following a corporate event (IPO) that triggers the conversion of existing securities into common stock. It provides transparency regarding the ownership structure of OS Therapies post-IPO.

Stakeholder Impact

• The disclosure provides transparency to shareholders regarding the ownership structure of the company after the IPO.

Key Dates